HQY vs WBS: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

WBS is the larger of the two ($12.57B market cap): the incumbent the market prices for continued execution (11.00x forward earnings, beta 1.00). HQY is the smaller challenger ($8.41B), actually pricier on forward earnings (18.42x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

HQY vs WBS: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricHQYWBSWhat it tells you
Market cap$8.41B$12.57BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E18.4211.00Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E36.6912.63Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.191.00Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range77% of range92% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book4.231.35How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: WBS is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how HQY and WBS affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HQY and WBS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HQY and WBS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does HealthEquity (HQY) do?

HealthEquity, Inc. is the largest independent non-bank custodian of health savings accounts in the United States, and it also administers the flexible spending accounts, health reimbursement arrangements, COBRA and commuter benefits that sit alongside them. As of April 30, 2026 it held 10.6 million HSAs containing $37.1 billion of member assets, plus 7.2 million other consumer-directed benefit accounts, for 17.8 million total accounts. Almost none of that comes from consumers directly: it reaches members through their employers, and employers through benefits brokers, health plans and retirement recordkeepers. Revenue arrives in three lines: service fees from employers and members, custodial revenue on the interest spread from member cash placed with insurance-company partners and banks, and interchange on every swipe of a member's benefits card. Custodial is the biggest and by far the most profitable, at $174.3 million of the $354.6 million booked in the quarter ended April 30, 2026, against only $11.7 million of direct cost.

Full HQY guide

What does Webster Financial Corporation (WBS) do?

Webster Financial Corporation (formerly NYSE: WBS) was a US regional bank holding company with more than $84 billion in total assets, headquartered in Stamford, Connecticut, and operating primarily across the Northeast. It ran three business lines: Commercial Banking (lending, treasury, and deposit services for middle-market and commercial clients), Consumer Banking (checking, savings, mortgages, and consumer lending across its branch network), and Healthcare Financial Services, home to HSA Bank, one of the largest administrators of health savings accounts in the country. Like most banks, Webster earned money mainly from net interest income (the spread between what it earns on loans and securities and what it pays on deposits), which it guided to roughly $2.47 to $2.50 billion for 2025, supplemented by fee income from deposit services, wealth management, and its HSA business.

Full WBS guide

HQY vs WBS: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • HQY drivers: The cash repricing ladder; Balances that compound whether or not accounts do.
  • WBS drivers: The Banco Santander acquisition, now completed; Regulatory approvals were the gating factor.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. For WBS, the deal-completion risk that dominated Webster in 2026 is gone: the Banco Santander merger closed in August 2026 and WBS no longer trades.

HQY or WBS: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick HQY if you believe its drivers more; WBS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HQY and WBS guides.

HQY vs WBS: the full fundamentals

HQY. HealthEquity runs a January fiscal year, so the quarter ended July 31, 2026 is fiscal 2027's second. At about $92 on October 16, 2026 the stock traded near 34x trailing GAAP earnings and about 17x forward estimates, with EV/EBITDA near 16x; debt of about $971 million against $256 million of cash keeps leverage modest. Because custodial revenue carries almost no direct cost, small changes in the yield on member cash swing earnings far more than equivalent changes in account count.

WBS. WBS has stopped trading, so these are final figures rather than a live valuation. In its last months the price was set by the Santander terms rather than by bank multiples: the deal was struck at roughly 2.0x fourth-quarter 2025 tangible book value, and the final close near 12.6x trailing earnings reflected the value of the cash plus Santander stock package. Figures are approximate.

Headline figures (approximate, October 2026): HQY shows revenue (ttm) ~$1.36B, latest quarter (q2 fy2027, ended july 31, 2026) ~$350.7M revenue, +7.6% year over year, q2 fy2027 earnings ~$65.6M net income, ~$1.24 adjusted EPS (vs ~$1.19 expected), margins (ttm) ~71% gross, ~28% operating; WBS shows deal outcome Acquired by Banco Santander; completion and delisting reported in a Form 8-K on Aug 20, 2026, per-share consideration $48.75 cash plus 2.0548 Santander ADS (~$75.59 at the Feb 2026 announcement), final close and market cap $77.57 on Aug 19, 2026; ~$12.6 billion, revenue (ttm to jun 2026) ~$2.8 billion; Q2 2026 revenue ~$740 million.

The bottom line: HQY vs WBS

HQY and WBS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HQY and WBS exposure against your real portfolio. It is not an investment adviser.

Wondering how HQY or WBS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about HealthEquity

Ask Walnut's AI anything about HQY and see how it fits what you own.

FAQ

What is the difference between HQY and WBS?

+

HealthEquity, Inc. Webster Financial Corporation (formerly NYSE: WBS) was a US regional bank holding company with more than $84 billion in total assets, headquartered in Stamford, Connecticut, and operating primarily across the Northeast. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is HQY or WBS the better stock?

+

Neither is universally better. WBS is the larger incumbent; HQY is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, HQY or WBS?

+

On forward P/E (as of November 2026), HQY trades at 18.42x and WBS at 11.00x, so WBS is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both HQY and WBS?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of HQY vs WBS?

+

HQY: Custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. Service revenue grew only 3% in the April 2026 quarter and average service fees per account are falling, which means growth in accounts is not translating cleanly into growth in fees. Competition for the employer default slot is intense, with Optum Bank, Fidelity and HSA Bank all able to undercut on price, and Fidelity in particular markets a no-fee individual HSA. A fiscal 2025 cybersecurity incident involving a business partner's compromised user account left the company facing a consolidated putative consumer class action in federal court in the District of Utah, where it filed a renewed motion to compel arbitration on May 15, 2026, plus several regulatory inquiries; separately, several plaintiff firms have publicized securities investigations following the March 2025 guidance reaction, though the latest 10-Q discloses no pending securities fraud case. Complementary benefit accounts (FSA, HRA, COBRA, commuter) were flat at 7.2 million, so the non-HSA half of the account base is not currently contributing growth. Leadership turnover is a newer watch point: the company terminated Chief Commercial Officer Michael Fiore in October 2026, a role tied directly to winning employer and partner accounts. WBS: The deal-completion risk that dominated Webster in 2026 is gone: the Banco Santander merger closed in August 2026 and WBS no longer trades. For former holders the remaining exposure depends on what they kept. The cash portion ($48.75 per share) is fixed, while the 2.0548 Santander ADS per share move with Santander's share price and the euro, so anyone still holding them carries Santander's risks: the usual bank credit cycle, where a recession or rising unemployment would increase loan losses, particularly in commercial real estate and consumer lending; interest-rate sensitivity, since net interest income is the largest revenue line and falling rates or deposit repricing can compress it; and integration risk, where merger disruption can cause customer or employee attrition at the former Webster franchise. Tax treatment of the cash-and-stock consideration depends on each holder's situation.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell HQY or WBS; figures are approximate and dated (as of November 2026). Verify current data before investing.